BackSynovics Pharmaceuticals Overview

Synovics Pharmaceuticals Receivables

Track Synovics Pharmaceuticals's receivables ($1.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.54M
↓ 58.34% YoYΔ $-2.16M vs prior year quarter

Peer trimmed avg / median

Loading

Synovics Pharmaceuticals Receivables History

Loading

Synovics Pharmaceuticals vs. peers: Receivables Comparison

Loading

Synovics Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Synovics Pharmaceuticals (SYVC) FAQ

Synovics Pharmaceuticals posts a receivables of $1.5M as of July 2009. That compares with $3.7M in the prior-year period — down 58.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Synovics Pharmaceuticals's receivables was $3.7M. The latest reading is $1.5M — a 58.3% year-over-year decrease (period ending July 2009). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Synovics Pharmaceuticals's financial statement story. At $1.5M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SYVC's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Synovics Pharmaceuticals's other metric pages and overview cover the third.

Judging Synovics Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $1.5M here, then scan peer and history charts to see if the gap is persistent.